Predictors of axillary lymph node metastases in patients with invasive breast carcinoma by a combination of classical and biological prognostic factors

Pathology Research and Practice

Volumn 195, Issue 9, 1999, Pages 611-618

  González Vela, M Carmen ^a   Garijo, M Francisca ^a   Fernández, Fidel A ^a   Buelta, Luis ^a   Val Bernal, J Fernando ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Axillary lymph node metastases; Breast carcinoma; MIB 1 index; Prognostic factors

Indexed keywords

BIOLOGICAL MARKER; CATHEPSIN D; ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CELL CYCLE S PHASE; CONTROLLED STUDY; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PLOIDY; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICS; TUMOR VOLUME;

EID: 19244383883     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(99)80126-5     Document Type: Article

References (37)

1. Ahlgren J, Stal O, Westman G, Arnesson LG (1994) Prediction of axillary lymph node metastases in a screened breast cancer population. Acta Oncologica 33: 603-608
2. Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis. A review. Int J Cancer 71: 1-22
3. Barth A, Craig PH, Silverstein MJ (1997) Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 79: 1918-1922
4. Chadha M, Chabon AB, Friedman P, Vikram B (1994) Predictors of axillary lymph node metastases in patients with T1 breast cancer. Cancer 73: 350-353
5. Clayton F, Hopkins CL (1993) Pathologic correlates of prognosis in lymph node positive breast carcinomas. Cancer 71: 1780-1790
6. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer (I). The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410
7. Fisher B, Redmond C, Fisher ER (1989) Ten-year results of a randomised clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 320: 491-496
8. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation associated human nuclear definided by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715
9. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222: 393-401
10. Giuliano AE, Jones RC, Brennan M, Statman R (1997) Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15: 2345-2350
11. Gonzalez-Vela MC, Garijo MF, Fernández F, Buelta L, Val-Bernal JF (1999) Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma. Histopathology 34: 35-42
12. Goulding H, Rashid NA, Robertson JF, Bell JA, Elston CW, Blarney RW, Ellis IO (1995) Assessment of angiogenesis in breast carcinoma: an important factor in prognosis?. Hum Pathol 26: 1196-1200
13. Horak ER, Leek R, Klenk N, Lejheune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL (1992) Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124
14. Hsu SM, Raine L, Fanger H. (1981) A comparative study of the peroxidase antiperoxidase method and an avidin biotin complex method for studying polypeptide hormones with radioimmuneassay antibodies. Am J Clin Pathol 75: 734-738
15. Ivens D, Hoe AL, Podd TJ (1992) Assessment of morbidity from complete axillary dissection. Br J Cancer 66: 136-138
16. Koukoulis GK, Patriarca C, Gould VE (1998) Adhesion molecules and tumor metastasis. Hum Pathol 29: 889-892
17. Lin PP, Allison DC, Wainstock J, Miller KD, Dooley WC, Friedman N, Baker RR (1993) Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 11: 1536-1544
18. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastases and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336
19. Longstreth WT Jr, Diehr P, Inui TS (1983) Prediction of awakening after out-of-hospital cardiac arrest. N Engl J Med 308: 1378-1382
20. MacDougall JR, Matrisian LM (1995) Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 14: 351-362
21. Margolese RG (1993) Axillary surgery in breast cancer-there still is a debate. Eur J Cancer 29A: 81
22. Marinho A, Soares R, Ferro J, Lacerda M, Schmitt FC (1997) Angiogenesis in breast cancer is related to age but not to other prognostic parameters. Pathol Res Pract 193: 267-273
23. Nadji M, Fresno M, Nassiri M, Conner G, Herrero A, Morales AR (1996) Cathepsin D in host stromal cells, but not in tumor cells, is associated with aggressive behaviour in node-negative breast cancer. Human Pathol 27: 890-895
24. Norton AJ, Jordan S, Yeomans P (1994) Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of a antigen retrieval for routinely processed tissues. J Pathol 173: 371-379
25. O'Donoghue AEMA , Poller DN, Bell JA, Galea MH, Elston CW, Blarney RW, Ellis IO (1995) Cathepsin D in primary breast carcinoma: adverse prognosis is associated with expression of cathepsin D in stromal cells. Breast Cancer Res Treat 32: 137-145
26. Okamura K, Kobayashi I, Matsuo K, Kiyoshima T, Yamamoto K, Miyoshi A, Sakai H (1997) Immunohistochemical localization of cathepsin D, proliferating cell nuclear antigen and epidermal growth factor receptor in human breast carcinoma analysed by computer image analyser: correlation with histological grade and metastatic behaviour. Histopathology 31: 540-548
27. Ravdin PM, DeLaurentis M, Vendely T, Clark GM (1994) Prediction of axillary lymph node status in breast cancer patients by use of prognostic factors. J Natl Cancer Inst 86: 1771-1775
28. Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S (1989) Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol 7: 1239-1251
29. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, ColburnWJ, Gamagami P (1994) Axillary lymph node dissection for Tla breast carcinoma. Is it indicated? Cancer 73: 664-667
30. Silverstein MJ, Gierson ED, Waisman JR, Colburn WJ, Gamagami P (1995). Prediction of axillary node positivity in patients with invasive carcinoma of the breast using a combination of T category and palpability. J Am Coll Surg 180: 700-704
31. Simpson JF, Dutt PL, Page DL.(1992) Expression of mitoses per thousand cells and cell density in breast carcinomas: a proposal. Hum Pathol 23: 608-611
32. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/ neu oncogene. Science 235: 177-182
33. van Diest PJ, Brugal G, Baak JPA (1998) Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol 51: 716-724
34. Vindelov LL, Christensen IJ, Nissen NJ (1983) A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323-327
35. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8
36. Weidner N, Moore DH, Valtanian R (1994) Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel paraffin reactive MIB1 antiboby. Hum Pathol 25: 337-342
37. Wright C, Angus B, Nicholson S, Sainsbury JRC, Cairns J, Gullick WJ, Kelly P, Harris AL, Home CHW (1989) Expression of c-erbB-2 oncoprotein: A prognostic indicator in human breast cancer. Cancer Res 49: 2087-2090